LAUSR

Bamlanivimab decreases severe outcomes of SARS-CoV-2 infection in ANCA vasculitis patients

Sign Up to like & get
recommendations!
0 Published in 2021 at "Kidney international reports"

DOI: 10.1016/j.ekir.2021.12.010

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive… read more here.

Keywords: cov infection; sars cov; bamlanivimab decreases; decreases severe ... See more keywords